Splash
Splash

Past Events

Past Events

27 February 2020 14:00 GMT 09:00 EST
Verona Pharma Full Year 2019 Financial Results and Conference Call

Conference call time: 9.00 am EST / 2.00 pm GMT.

To participate, please dial one of the following numbers and reference conference ID 5394158:

  • 866-940-4574 for callers in the United States
  • 0800 028 8438 for callers in the United Kingdom
  • 0800 181 5287 for callers in Germany
4 February 2020 13:45 GMT 08:45 EST
LSX World Congress 2020
13 January 2020 14:00 GMT 09:00 EST
Verona Pharma to Report 4 Week Phase 2b COPD Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
20 November 2019 17:20 GMT 12:20 EST
Jefferies 2019 London Healthcare Conference
19 November 2019 13:00 GMT 08:00 EST
Stifel 2019 Healthcare Conference
Presenter: Jan-Anders Karlsson, CEO
18 November 2019 05:00 GMT 00:00 EST
Guggenheim Healthcare Talks Idea Forum | Neuro/Immunology Day
5 November 2019 13:00 GMT 08:00 EST
Verona Pharma Third Quarter 2019 Financial Results and Conference Call

To participate, please dial one of the following numbers and reference conference ID 6498479:

866-940-4574 for callers in the United States
0800 028 8438 for callers in the United Kingdom
0800 181 5287 for callers in Germany

10 September 2019 19:00 GMT 14:00 EST
2019 H.C. Wainwright 21st Annual Global Investment Conference
5 August 2019 12:00 GMT 07:00 EST
Ensifentrine (RPL554) Positive Data from 7-Day Phase 2 Clinical Trial in COPD Patients with Dry Powder Inhaler Formulation
6 August 2019 12:00 GMT 07:00 EST
Verona Pharma Second Quarter 2019 Financial Results and Conference Call
13 August 2019 17:55 GMT 12:55 EST
2019 Wedbush PacGrow Healthcare Conference

Supporting materials

Wedbush Presentation

12 August 2019 04:00 GMT 23:00 EST
BTIG Biotechnology Conference 2019
5 June 2019 12:30 GMT 07:30 EST
Jefferies 2019 Global Healthcare Conference

Jan-Anders Karlsson, Chief Executive Officer and Executive Director

20 May 2019 04:00 GMT 23:00 EST
Expanded Analysis of Clinical Data at ATS 2019
8 May 2019 04:00 GMT 23:00 EST
Investor & Analyst R&D Forum London 2019
7 May 2019 12:00 GMT 07:00 EST
Verona Pharma First Quarter 2019 Financial Results and Conference Call
8 April 2019 16:30 GMT 11:30 EST
H.C Wainwright Global Life Sciences Conference
7 May 2019 09:00 GMT 04:00 EST
Annual General Meeting of Shareholders
Click here for more information
12 March 2019 13:00 GMT 08:00 EST
Verona Pharma presents at Ligand Pharmaceuticals Analyst Day

Supporting materials

Ligand presentation

13 March 2019 14:00 GMT 09:00 EST
Cowen and Company 39th Annual Health Care Conference

Supporting materials

Cowen presentation

26 February 2019 13:00 GMT 08:00 EST
Verona Pharma Full Year 2018 Financial Results and Conference Call
14 January 2019 13:00 GMT 08:00 EST
Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment
7 January 2019 23:23 GMT 18:23 EST
JP Morgan Conference

Supporting materials

JP Morgan Conference

21 December 2018 17:35 GMT 12:35 EST
Citi Healthcare Conference
13 November 2018 13:45 GMT 08:45 EST
Verona Pharma to Present at Stifel 2018 Healthcare Conference
6 November 2018 13:00 GMT 08:00 EST
Verona Pharma Third Quarter 2018 Financial Results and Conference Call
12 October 2018 15:00 GMT 10:00 EST
Investor & Analyst R&D Forum
18 September 2018 12:00 GMT 07:00 EST
Verona Pharma Presents Expanded Dataset from RPL554 Phase 2b Clinical Trial in COPD Presented at European Respiratory Society International Congress
Splash

© Verona Pharma plc 2020. All rights reserved